Related Experiment Video
Updated: Dec 20, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Tubulointerstitial Nephritis and Uveitis Syndrome: Characterization of Clinical Features
Anjum F Koreishi1, Mei Zhou1, Debra A Goldstein1
1Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Tubulointerstitial nephritis and uveitis syndrome (TINU) affects all ages, frequently involving posterior eye segments. Most patients require systemic steroids, and many need long-term immunomodulatory therapy for TINU.
Area of Science:
- Ophthalmology
- Nephrology
- Immunology
Background:
- Tubulointerstitial nephritis and uveitis syndrome (TINU) is a rare condition.
- Understanding its clinical spectrum, particularly posterior segment involvement, is crucial for diagnosis and management.
Purpose of the Study:
- To detail the clinical manifestations of TINU patients.
- To emphasize posterior segment ocular findings in TINU.
Main Methods:
- Retrospective chart review of 17 patients diagnosed with TINU.
- Analysis of clinical presentations and treatment outcomes.
Main Results:
- TINU presented across all age groups (7-49 years), with a female predominance (59%).
- Posterior segment findings were common (65%), including disc edema (41%) and macular edema (24%).
- Elevated urine β2-microglobulin confirmed renal involvement; 65% required systemic steroids and 41% needed immunomodulatory therapy.
Conclusions:
- TINU is not limited to specific age groups and commonly affects the posterior eye segment.
- Effective management often involves systemic steroids and potentially long-term immunomodulation.
- Comprehensive funduscopic examination is essential for all TINU patients.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Chronic Kidney Disease II: Clinical Manifestations
Acute Pyelonephritis I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Urinary Tract Infection II: Pathophysiology

